2022. Capmatinib in patients with MET-positive advanced non-small cell lung cancer: analysis of the Russian cohort in the Geometry mono-1 study. Voprosy onkologii. 68, 6 (Dec. 2022), 758–767. DOI:https://doi.org/10.37469/0507-3758-2022-68-6-758-767.